Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
To evalute the safety and efficacy in reducing Cytokine Release Syndrome after hematopoietic stem cell transplantation by introducing immunosuppression earlier…
Hematologic Disease and DisordersHematopoietic Cell Transplant
Northside Hospital, Inc.NCT06828796
Phase 1
A Phase 1 Study to Evaluate the Safety of KLN-1010, a Novel, In Vivo Gene Therapy to Generate Anti-B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor-T Cells (CAR-T) in Patients With Relapsed and Refractory Multiple Myeloma
The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractor…
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Kelonia Therapeutics, Inc.NCT07075185